Wisner Baum Investigates Generic Drug Quality as 2026 Patent Cliff Accelerates Competition
Attorney Behram Parekh sees independent testing, patient education, and real-world evidence as necessary steps in ensuri …
Before Choosing a Transparent PBM, Employers Should Ask These 10 Questions
US-Rx Care urges employers and benefits providers to use contract-level tests covering fiduciary responsibility, conflic …
Why Every Professional Services Firm Sounds the Same (and Why That's Costing You Clients)
A recent professional-services positioning study found that 81% of B2B buyers now say service businesses “all sound the …
FlyUSA Launches $100 Million Jet Card Recovery Program for Private Flyers with Stranded Funds
Qualifying customers receive a complimentary FlyUSA Gold Membership valued at $4,995, pay as they go with no deposit req …
Wisner Baum Calls for Stronger Barriers Between the EPA and the Chemical Industry
The revolving door between the EPA and chemical manufacturers has persisted for decades, across administrations of both …
Companies Are Giving AI More Authority Than Accountability
As AI moves from generating answers to taking actions inside business workflows, JOTO PR points to a widening gap betwee …
AI Cyberattacks. The Industry Gives Warning. WinMagic Gives the Fix.
As more than 150 technology, cybersecurity, and financial organizations warn of accelerating AI-enabled attacks, WinMagi …
AI Markets Are Mis-Pricing Capacity as Profit, New Constructs Warns
With five major cloud operators expected to spend $1.2 trillion on artificial intelligence infrastructure in 2027, New C …
B2B Buyers Choose Favorites Before Sales Calls. Breaker Says Newsletters Win the Long Tail
With average B2B buying cycles lasting about 10 months and 95% winning vendors appearing on buyers' day-one shortlists, …
SHARx Urges HR and CFO Leaders to Rethink the True Cost of Pharmacy Benefits
As prescription spending continues to squeeze benefits budgets, SHARx says employers should measure the consequences in …
